Can RFK Jr. Limit Ozempic Access as HHS Chief? Here's What to Know

By The New York Times | Nov 22, 2024 at 04:08 PM EST

President-elect Donald J. Trump plans to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department. Kennedy criticizes drugs like Ozempic, but as secretary, he cannot revoke drug approvals. He may face legal challenges if he tries.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.